Samsung Biologics
207940.KS
$559.32
Share price
-1.28%
Change (1 day)
-4.21%
Change (1 year)
Categories
Samsung Biologics (207940.KS) - Total assets
Total assets on the balance sheet as of December 2023 : $12.40 B
According to Samsung Biologics 's latest financial reports the company's total assets are $12.40 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Samsung Biologics - Total assets on balance sheet (from 2016 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $12.40 B | -5.67% |
| 2022-12-31 | $13.15 B | 96.34% |
| 2021-12-31 | $6.69 B | 13.27% |
| 2020-12-31 | $5.91 B | 15.67% |
| 2019-12-31 | $5.11 B | -4.57% |
| 2018-12-31 | $5.35 B | -20.49% |
| 2017-12-31 | $6.73 B | 7.82% |
| 2016-12-31 | $6.24 B | 23.24% |
| 2015-12-31 | $5.07 B | 309.69% |
| 2014-12-31 | $1.23 B |